Results 11 to 20 of about 134,663 (283)
Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza virus that expresses an altered nucleoprotein sequence [PDF]
, 2013 Influenza virus poses a difficult challenge for protective immunity. This virus is adept at altering its surface proteins, the proteins that are the targets of neutralizing antibody.
A Endo +51 more
core +9 more sources
New-age vaccine adjuvants, their development, and future perspective
Frontiers in Immunology, 2023 In the present scenario, immunization is of utmost importance as it keeps us safe and protects us from infectious agents. Despite the great success in the field of vaccinology, there is a need to not only develop safe and ideal vaccines to fight deadly ...
Shailendra Kumar Verma +6 more
doaj +1 more source
The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models. [PDF]
, 2016 Toll-like receptors (TLRs) play an important role in the innate and adaptive immune responses to pathogens, and are the target of new vaccine adjuvants.
Bates, PA +4 more
core +7 more sources
Surgical Clinics of North America, 1986 At present, adjuvant chemotherapy exerts no significant impact on long-term survival and only occasionally provides brief palliation in head and neck cancer. The major contribution of chemotherapy has been in the preoperative period, when therapy for advanced squamous cell carcinoma may render some patients candidates for curative operations or ...
C K, Osborne, C A, Coltman
openaire +4 more sources
Journal of Fungi, 2019 Clonostachys rosea strain ACM941 is an effective biocontrol agent against several crop diseases including Fusarium head blight. In anticipation of its increased relevance going forward, the development of a reliable DNA-based molecular marker to track it
Zerihun A. Demissie +2 more
doaj +1 more source
Vaccines against toxoplasma gondii : challenges and opportunities [PDF]
, 2009 Development of vaccines against Toxoplasma gondii infection in humans is of high priority, given the high burden of disease in some areas of the world like South America, and the lack of effective drugs with few adverse effects.
Aliberti J +117 more
core +3 more sources
HPB, 2006 Exocrine pancreatic cancer (pancreatic ductal adenocarcinoma) is one of the leading causes of cancer deaths in the western world, accounting for 5% of all cancer-related deaths. Only a small percentage of patients with pancreatic cancer are able to undergo potentially curative resection, even in specialized centres, and prognosis remains poor after ...
Sultana, Asma +2 more
openaire +2 more sources
Barnyardgrass shows sensitivity to reduced doses of topramezone at different growth stages [PDF]
, 2019 Using less than the labelled dose of herbicides depends mostly on weed spectrum and growth stage of target weeds. The aim of the greenhouse experiment was to determine the efficacy of recommended (67.2 g a.i. ha-1) and reduced doses (44.8, 33.6, 22.4, 16.
\u160\u107epanovi\u107, Maja +4 more
core +1 more source
Immunogens and Antigen Processing: Report from a Global HIV Vaccine Enterprise Working Group [PDF]
, 2010 The Global HIV Vaccine Enterprise convened a meeting of a Working Group in July 2009 to discuss recent progress in rational design of the components of an HIV vaccine, such as inserts, vectors and adjuvants,and in understanding antigen processing and ...
John Mascola +3 more
core +3 more sources
A comparison of cancer vaccine adjuvants in clinical trials
Cancer Treatment and Research Communications, 2023 Cancer treatment has come a long way in increasing overall survival; however, evasion of the immune system continues to be a challenge in treating individuals with established disease burdens.
Morgan Marriott +2 more
doaj +1 more source